Detailed Structural Analysis of Amyloidogenic Wild-Type Transthyretin Using a Novel Purification Strategy and Mass Spectrometry
- 30 January 2007
- journal article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 79 (5) , 1990-1998
- https://doi.org/10.1021/ac061546s
Abstract
Wild-type transthyretin (TTR), normally a soluble plasma-circulating protein, can be amyloidogenic, i.e., form tissue-deposited fibrillar material in the extracellular matrix of various organs throughout the body. Senile systemic amyloidosis (SSA) is one such pathology and features TTR-containing amyloid deposits that are found primarily in the heart. The cause for this transition from soluble to insoluble protein in SSA is yet to be determined as specific structural features that might favor TTR fibrillogenesis have not yet been identified. The precise characterization of ex vivo fibril deposits might provide insight, but structural analyses of TTR from amyloid deposits have been hindered thus far by the lack of purification strategies that overcome the insolubility of the tissue-derived protein without degrading it. Consequently, the true biochemical nature of deposited TTR remains in question. In this study, we provide detailed analyses of both the soluble (serum) and deposited (tissue) forms of TTR from cases of SSA. In the serum, a distribution of mixed disulfides, specifically S-sulfonated and S-cysteinylated forms of TTR, as well as the unmodified protein were identified. The relative levels of the three TTR species in the SSA group were comparable to amounts present in sera from age-matched control groups. For characterization of the amyloid deposited TTR, we investigated cardiac tissue samples obtained from three separate cases of SSA. We report a novel chromatographic purification strategy performed under nonreducing conditions (to maintain cysteine disulfide status) and the use of this procedure in conjunction with detailed mass spectrometric analysis of TTR from the amyloid deposits. A series of C-terminal TTR fragments with N-termini ranging from amino acids 46 to 55 were identified. We also determined that the deposits in all samples contained Cys10 disulfide-linkedhomodimers composed of full-length TTR monomers. This last finding suggests an important role for Cys10 conjugation in the transition from soluble TTR to the pathological amyloid fibril.Keywords
This publication has 16 references indexed in Scilit:
- Amyloid deposits in transthyretin‐derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphologyThe Journal of Pathology, 2005
- Biophysical Analyses of the Transthyretin Variants, Tyr114His and Tyr116Ser, Associated with Familial Amyloidotic PolyneuropathyBiochemistry, 2003
- Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolutionJournal of Molecular Biology, 2001
- The Tetrameric Protein Transthyretin Dissociates to a Non-native Monomer in SolutionJournal of Biological Chemistry, 1999
- Top Down versus Bottom Up Protein Characterization by Tandem High-Resolution Mass SpectrometryJournal of the American Chemical Society, 1999
- A new transthyretin variant (Ser2 sn) associated with familial amyloidosis in a Portuguese patientAmyloid, 1999
- Characterization of Transthyretin Mutants from Serum Using Immunoprecipitation, HPLC/Electrospray Ionization and Matrix-Assisted Laser Desorption/Ionization Mass SpectrometryAnalytical Chemistry, 1998
- Characterization of the Transthyretin Acid Denaturation Pathways by Analytical Ultracentrifugation: Implications for Wild-Type, V30M, and L55P Amyloid Fibril FormationBiochemistry, 1998
- Interpreting mass spectra of multiply charged ionsAnalytical Chemistry, 1989
- Frequency and distribution of senile cardiovascular amyloidThe American Journal of Medicine, 1983